The F15-NOD Nfκb1 heterozygote and homozygote mice, which are considered at risk of developing myocarditis, were found to have an increased risk of myocarditis after influenza hemagglutinin (HA) or HBV vaccination. This evidence concerns the gene NFKB1 and myocarditis.